# Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis

> **NCT00454519** · PHASE2 · UNKNOWN · sponsor: **Wuhan University** · enrollment: 60 (estimated)

## Conditions studied

- Stomach Neoplasms
- Colorectal Neoplasms
- Neoplasm Metastasis
- Mesothelioma

## Interventions

- **PROCEDURE:** cytoreductive surgery
- **PROCEDURE:** intraoperative peritoneal hyperthermic chemotherapy with cisplatin and mitomycin

## Key facts

- **NCT ID:** NCT00454519
- **Lead sponsor:** Wuhan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-03
- **Primary completion:** 2009-12
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-02-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00454519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00454519, "Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00454519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*